Auravax Therapeutics
UEI: PAN3ZK2YLAL2
• CAGE: 969E2
Overview
Awardee Type
Parent
Name
Auravax Therapeutics
Website
Headquarters
Houston, TX
United States
United States
Most Recent Award
Sept. 23, 2024
Calculating
Federal contract recipient
AURAVAX THERAPEUTICS, INC.
(UEI PAN3ZK2YLAL2, CAGE 969E2)
is headquartered in Houston TX.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in August 2020 and
federally registered in
October 2021.
Federal Award Analysis
Auravax Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AURAVAX THERAPEUTICS, INC.
Division Name
AURAVAX
UEI
PAN3ZK2YLAL2
CAGE Code
969E2
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 14, 2020
Initial Registration
Oct. 1, 2021
Last Registration
March 11, 2025
Registration Activation
March 10, 2025
Registration Expiration
March 6, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported PSC
Accepts Credit Cards
No